China’s Covid-19 vax is safe, prompts antibody response: Lancet
Beijing: Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.
A previous clinical trial…